HRSA Office of Pharmacy Affairs (OPA)
has a process for registering covered entities who choose to
participate in the section 340B Drug Pricing Program. These
entities must comply with the requirements of 340B (a)(5)(A) of the
PHS Act. The 340B Drug Pricing Program forms allow entities to
provide registration and certifying information and to determine
eligibility for the progam.
This is a request for a
non-material or non-substantive change to increase the estimated
number of respondents and reflect the covered entities that are
newly eligible to participate in the 340B Program due to Section
7101 of the Patient Protection and Affordable Care Act. This
non-substantive change will impose an estimated annual average
total burden of an additional 1,306 hours.
$44,203
No
No
Yes
Uncollected
No
Uncollected
Susan Queen 3014431129
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.